Two senior Boehringer Ingelheim executives, Joachim Hasenmaier and Felix Gutsche, discuss the global pharmaceutical company’s deal with Sanofi to acquire its animal health business
Bringing an animal health business into the fold
Published
Two senior Boehringer Ingelheim executives, Joachim Hasenmaier and Felix Gutsche, discuss the global pharmaceutical company’s deal with Sanofi to acquire its animal health business